Page last updated: 2024-08-21

9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-7h-furo(3,2-g)(1)benzopyran-7-one and Disease Models, Animal

9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-7h-furo(3,2-g)(1)benzopyran-7-one has been researched along with Disease Models, Animal in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
He, L; Jia, Y; Peng, J; Qian, Y; Sun, P; Wang, Y; Yang, Q; Yang, W; Zhang, T; Zhao, K1
Bai, J; Bi, Z; Li, H; Li, X; Ma, B; Ma, X; Ning, W; Shao, S; Wei, Y; Xie, C; Yang, C; Zhang, L; Zhang, R; Zhang, S; Zhou, H1
Jung, H; Kang, YY; Kim, JY; Lim, Y; Mok, H; Song, J; Yeo, WS1

Other Studies

3 other study(ies) available for 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-7h-furo(3,2-g)(1)benzopyran-7-one and Disease Models, Animal

ArticleYear
Byakangelicin inhibits IL-1β-induced mouse chondrocyte inflammation in vitro and ameliorates murine osteoarthritis in vivo.
    International immunopharmacology, 2020, Volume: 85

    Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chondrocytes; Cyclooxygenase 2; Disease Models, Animal; Furocoumarins; Interleukin-1beta; Male; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Osteoarthritis; Tumor Necrosis Factor-alpha

2020
Byakangelicin protects against carbon tetrachloride-induced liver injury and fibrosis in mice.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:15

    Topics: Animals; Apoptosis; Biopsy; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Furocoumarins; Hepatic Stellate Cells; Hepatocytes; Liver Cirrhosis; Male; Mice; Protective Agents; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta

2020
Byakangelicin as a modulator for improved distribution and bioactivity of natural compounds and synthetic drugs in the brain.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 62

    Topics: Administration, Intravenous; Animals; Brain; Curcumin; Disease Models, Animal; Doxorubicin; Female; Furocoumarins; Humans; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Neurogenic Inflammation; Umbelliferones

2019